HER2-low expression in patients with advanced or metastatic solid tumors.

Uzunparmak B, Haymaker C, Raso G, Masciari S, Wang L, Lin H, Gorur A, Kirby B, Cimo AM, Kennon A, Ding Q, Urschel G, Yuan Y, Feng G, Rizvi Y, Hussain A, Zhu C, Kim P, Abbadessa G, Subbiah V, Yap TA, Rodon J, Piha-Paul SA, Meric-Bernstam F, Dumbrava EE

Open source

DOI: 10.1016/j.annonc.2023.08.005
Published: 2023 Nov
Container: Annals of oncology : official journal of the European Society for Medical Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.annonc.2023.08.005,
  title = {HER2-low expression in patients with advanced or metastatic solid tumors.},
  author = {Uzunparmak B and Haymaker C and Raso G and Masciari S and Wang L and Lin H and Gorur A and Kirby B and Cimo AM and Kennon A and Ding Q and Urschel G and Yuan Y and Feng G and Rizvi Y and Hussain A and Zhu C and Kim P and Abbadessa G and Subbiah V and Yap TA and Rodon J and Piha-Paul SA and Meric-Bernstam F and Dumbrava EE},
  year = {2023},
  journal = {Annals of oncology : official journal of the European Society for Medical Oncology},
  doi = {10.1016/j.annonc.2023.08.005},
  url = {https://doi.org/10.1016/j.annonc.2023.08.005}
}

RIS

TY  - JOUR
TI  - HER2-low expression in patients with advanced or metastatic solid tumors.
AU  - Uzunparmak B
AU  - Haymaker C
AU  - Raso G
AU  - Masciari S
AU  - Wang L
AU  - Lin H
AU  - Gorur A
AU  - Kirby B
AU  - Cimo AM
AU  - Kennon A
AU  - Ding Q
AU  - Urschel G
AU  - Yuan Y
AU  - Feng G
AU  - Rizvi Y
AU  - Hussain A
AU  - Zhu C
AU  - Kim P
AU  - Abbadessa G
AU  - Subbiah V
AU  - Yap TA
AU  - Rodon J
AU  - Piha-Paul SA
AU  - Meric-Bernstam F
AU  - Dumbrava EE
PY  - 2023
JO  - Annals of oncology : official journal of the European Society for Medical Oncology
DO  - 10.1016/j.annonc.2023.08.005
UR  - https://doi.org/10.1016/j.annonc.2023.08.005
ER  -

APA

B, U., C, H., G, R., S, M., L, W., H, L., A, G., B, K., AM, C., A, K., Q, D., G, U., Y, Y., G, F., Y, R., A, H., C, Z., P, K., G, A., V, S., TA, Y., J, R., SA, P., F, M., & EE, D. (2023). HER2-low expression in patients with advanced or metastatic solid tumors.. Annals of oncology : official journal of the European Society for Medical Oncology. https://doi.org/10.1016/j.annonc.2023.08.005

Source records

pubmed · retrieved 2026-09-27T07:33:56.007Z